CASTRATE RESISTANT PROSTATE CANCER
Clinical trials for CASTRATE RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATE RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATE RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat cancers? early trial launches
Disease control Recruiting nowThis early-phase study is testing an experimental drug called DR-0202 in people with advanced solid tumors (like breast, lung, or pancreatic cancer) that have stopped responding to standard treatments. The main goal is to check the drug's safety and find the right dose. About 96 …
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study is testing an experimental drug called ETX-19477 in people with advanced solid tumors (like breast, ovarian, or prostate cancer) that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors or slow their…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: 858 Therapeutics, Inc. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New drug combo aims to slow advanced prostate cancer
Disease control Recruiting nowThis study tests whether combining two drugs—pembrolizumab (an immunotherapy) and 177Lu-PSMA-617 (a targeted radiation therapy)—can slow the growth of advanced prostate cancer that has stopped responding to hormone treatments. About 48 men with metastatic castration-resistant pro…
Matched conditions: CASTRATE RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 19, 2026 11:48 UTC